<--- Back to Details
First PageDocument Content
Medicinal chemistry / Pharmacodynamics / Pharmacokinetics / Clinical pharmacology / Biological databases / Drug interaction / Pharmaceutical drug / KEGG / Drug action / DrugBank / Drug class / Mechanism of action
Date: 2009-11-09 00:37:02
Medicinal chemistry
Pharmacodynamics
Pharmacokinetics
Clinical pharmacology
Biological databases
Drug interaction
Pharmaceutical drug
KEGG
Drug action
DrugBank
Drug class
Mechanism of action

Microsoft Word - 05-Takarabe.doc

Add to Reading List

Source URL: www.jsbi.org

Download Document from Source Website

File Size: 820,17 KB

Share Document on Facebook

Similar Documents

Converting KEGG pathway database to SBML Akira Funahashi 1,2,*  2,*

Converting KEGG pathway database to SBML Akira Funahashi 1,2,* 2,*

DocID: 1u3fp - View Document

Resume of: 	Dr. Richard L. Kegg

Resume of: Dr. Richard L. Kegg

DocID: 1rqt0 - View Document

September 14, :56 WSPC - Proceedings Trim Size: 9.75in x 6.5in

September 14, :56 WSPC - Proceedings Trim Size: 9.75in x 6.5in

DocID: 1rp6P - View Document

The MicroScope platform: from data integration to a rule-based system for massive and high-quality microbial genome annotation Jonathan MERCIER, Alexandre RENAUX, Adrien JOSSO, Aurélie GENIN-LAJUS, E’Krame JACOBY, Fra

The MicroScope platform: from data integration to a rule-based system for massive and high-quality microbial genome annotation Jonathan MERCIER, Alexandre RENAUX, Adrien JOSSO, Aurélie GENIN-LAJUS, E’Krame JACOBY, Fra

DocID: 1reRz - View Document

Phase 4: Variant prioritisation  Even with sound experimental design and variant filtering protocols, whole exome sequencing studies often still produce many more candidates than can be verified experimentally. While pos

Phase 4: Variant prioritisation Even with sound experimental design and variant filtering protocols, whole exome sequencing studies often still produce many more candidates than can be verified experimentally. While pos

DocID: 1r6r6 - View Document